Parkinson's disease: etiopathogenesis and treatment

J Jankovic, EK Tan - Journal of Neurology, Neurosurgery & Psychiatry, 2020 - jnnp.bmj.com
The concept of 'idiopathic'Parkinson's disease (PD) as a single entity has been challenged
with the identification of several clinical subtypes, pathogenic genes and putative causative …

Parkinson's disease: clinical features and diagnosis

J Jankovic - Journal of neurology, neurosurgery & psychiatry, 2008 - jnnp.bmj.com
Objective: Parkinson's disease (PD) is a progressive neurological disorder characterised by
a large number of motor and non-motor features that can impact on function to a variable …

[HTML][HTML] Parkinson's: a syndrome rather than a disease?

N Titova, C Padmakumar, SJG Lewis… - Journal of Neural …, 2017 - Springer
Emerging concepts suggest that a multitude of pathology ranging from misfolding of alpha-
synuclein to neuroinflammation, mitochondrial dysfunction, and neurotransmitter driven …

Parkinson's disease: a short story of 200 years

L Cuenca, AL Gil Martinez, L Cano Fernandez… - 2019 - digitum.um.es
After Alzheimer's disease, Parkinson's disease (PD) is the second most prevalent and
incidental neurodegenerative disorder, affecting more than 2% of the population older than …

Pathophysiology and treatment of psychosis in Parkinson's disease: a review

LB Zahodne, HH Fernandez - Drugs & aging, 2008 - Springer
Psychotic symptoms in Parkinson's disease (PD) are relatively common and, in addition to
creating a disturbance in patients' daily lives, have consistently been shown to be …

Present and future drug treatment for Parkinson's disease

AHV Schapira - Journal of Neurology, Neurosurgery & Psychiatry, 2005 - jnnp.bmj.com
Considerable advances made in defining the aetiology, pathogenesis, and pathology of
Parkinson's disease (PD) have resulted in the development and rapid expansion of the …

Parkinson's disease: pathogenesis and clinical aspects [internet]

TB Stoker, JC Greenland - 2018 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease is an increasingly common neurodegenerative condition, which causes
not only dysfunction of movement but also a broad range of nonmotor features, including …

[HTML][HTML] Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

P Maiti, J Manna, GL Dunbar - Translational neurodegeneration, 2017 - Springer
Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars
compacta and subsequent reduction of dopamine levels in striatum are associated with …

The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future

S Fahn - Parkinsonism & related disorders, 2018 - Elsevier
It took almost 100 years before a meaningful advance occurred in any basic science
understanding of Parkinson disease (PD) following James Parkinson's description in 1817 …

Awareness and current knowledge of Parkinson's disease: a neurodegenerative disorder

AU Khan, M Akram, M Daniyal… - International Journal of …, 2019 - Taylor & Francis
Context: Parkinson's disease (PD) is the second common progressive neurodegenerative
disease, distressing older men and is prevalent Worldwide. Objectives: This article is aimed …